nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.127	0.137	CbGbCtD
Remoxipride—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.12	0.129	CbGbCtD
Remoxipride—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.12	0.129	CbGbCtD
Remoxipride—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.108	0.116	CbGbCtD
Remoxipride—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.108	0.116	CbGbCtD
Remoxipride—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0934	0.1	CbGbCtD
Remoxipride—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0907	0.0974	CbGbCtD
Remoxipride—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.082	0.0881	CbGbCtD
Remoxipride—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.082	0.0881	CbGbCtD
Remoxipride—DRD2—nerve—acquired immunodeficiency syndrome	0.00458	0.0927	CbGeAlD
Remoxipride—HTR2A—nerve—acquired immunodeficiency syndrome	0.00302	0.0612	CbGeAlD
Remoxipride—DRD4—brain—acquired immunodeficiency syndrome	0.00265	0.0536	CbGeAlD
Remoxipride—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00257	0.0521	CbGeAlD
Remoxipride—DRD3—nervous system—acquired immunodeficiency syndrome	0.00243	0.0493	CbGeAlD
Remoxipride—DRD3—central nervous system—acquired immunodeficiency syndrome	0.00234	0.0475	CbGeAlD
Remoxipride—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00228	0.0463	CbGeAlD
Remoxipride—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00208	0.0421	CbGeAlD
Remoxipride—DRD2—retina—acquired immunodeficiency syndrome	0.0019	0.0384	CbGeAlD
Remoxipride—DRD3—brain—acquired immunodeficiency syndrome	0.00186	0.0377	CbGeAlD
Remoxipride—SIGMAR1—blood—acquired immunodeficiency syndrome	0.00157	0.0318	CbGeAlD
Remoxipride—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.00152	0.0308	CbGeAlD
Remoxipride—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.00151	0.0306	CbGeAlD
Remoxipride—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.00145	0.0295	CbGeAlD
Remoxipride—SIGMAR1—lung—acquired immunodeficiency syndrome	0.00138	0.0279	CbGeAlD
Remoxipride—HTR2A—retina—acquired immunodeficiency syndrome	0.00125	0.0253	CbGeAlD
Remoxipride—DRD2—lung—acquired immunodeficiency syndrome	0.00111	0.0225	CbGeAlD
Remoxipride—DRD2—nervous system—acquired immunodeficiency syndrome	0.00103	0.0209	CbGeAlD
Remoxipride—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000991	0.0201	CbGeAlD
Remoxipride—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000974	0.0197	CbGeAlD
Remoxipride—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000941	0.0191	CbGeAlD
Remoxipride—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000878	0.0178	CbGeAlD
Remoxipride—HTR2A—blood—acquired immunodeficiency syndrome	0.000836	0.0169	CbGeAlD
Remoxipride—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000806	0.0163	CbGeAlD
Remoxipride—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.0008	0.0162	CbGeAlD
Remoxipride—DRD2—brain—acquired immunodeficiency syndrome	0.000787	0.0159	CbGeAlD
Remoxipride—HTR2A—vagina—acquired immunodeficiency syndrome	0.000775	0.0157	CbGeAlD
Remoxipride—CYP2D6—blood—acquired immunodeficiency syndrome	0.000762	0.0154	CbGeAlD
Remoxipride—HTR2A—lung—acquired immunodeficiency syndrome	0.000733	0.0149	CbGeAlD
Remoxipride—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000679	0.0138	CbGeAlD
Remoxipride—DRD4—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000675	0.0349	CbGpPWpGaD
Remoxipride—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000654	0.0132	CbGeAlD
Remoxipride—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000618	0.0125	CbGeAlD
Remoxipride—DRD3—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.0006	0.031	CbGpPWpGaD
Remoxipride—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000595	0.0121	CbGeAlD
Remoxipride—DRD4—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000584	0.0302	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000519	0.0269	CbGpPWpGaD
Remoxipride—HTR2A—brain—acquired immunodeficiency syndrome	0.000519	0.0105	CbGeAlD
Remoxipride—CYP2D6—brain—acquired immunodeficiency syndrome	0.000473	0.00958	CbGeAlD
Remoxipride—DRD2—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000459	0.0237	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000391	0.0202	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000359	0.0186	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000319	0.0165	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000273	0.0141	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000244	0.0126	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000243	0.0126	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00024	0.0124	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000217	0.0113	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00021	0.0109	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000197	0.0102	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000193	0.00999	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000187	0.00967	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000186	0.00961	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000183	0.00946	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000175	0.00904	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000166	0.00857	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000153	0.00791	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00015	0.00775	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000148	0.00765	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000147	0.00761	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000145	0.00752	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000144	0.00743	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000144	0.00743	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000142	0.00734	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000141	0.00728	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00014	0.00726	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000136	0.00702	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000134	0.00695	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000134	0.00692	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000133	0.0069	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000133	0.00688	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000132	0.00681	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000128	0.0066	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000128	0.0066	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000126	0.00652	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000125	0.00645	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000121	0.00629	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000119	0.00617	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000118	0.00613	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000114	0.00591	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000114	0.00591	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000113	0.00582	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000111	0.00573	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000109	0.00566	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000108	0.00558	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000104	0.00537	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000102	0.00529	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000102	0.00527	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000101	0.00525	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000101	0.00525	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	0.000101	0.00523	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0001	0.00518	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	9.85e-05	0.00509	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	9.76e-05	0.00505	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	9.76e-05	0.00505	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	9.71e-05	0.00502	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	9.64e-05	0.00499	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	9.53e-05	0.00493	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	9.48e-05	0.00491	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	9.38e-05	0.00485	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.25e-05	0.00479	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.14e-05	0.00473	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.13e-05	0.00472	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.09e-05	0.0047	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.06e-05	0.00469	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	8.98e-05	0.00465	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	8.92e-05	0.00461	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	8.75e-05	0.00453	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.7e-05	0.0045	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.7e-05	0.0045	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.69e-05	0.0045	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.5e-05	0.0044	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.29e-05	0.00429	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.26e-05	0.00427	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.22e-05	0.00425	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.12e-05	0.0042	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.12e-05	0.0042	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.83e-05	0.00405	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.76e-05	0.00402	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	7.76e-05	0.00402	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.73e-05	0.004	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.73e-05	0.004	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.72e-05	0.00399	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.68e-05	0.00398	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.64e-05	0.00395	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	7.64e-05	0.00395	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.55e-05	0.00391	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	7.43e-05	0.00384	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.36e-05	0.00381	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	6.95e-05	0.0036	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.95e-05	0.0036	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	6.84e-05	0.00354	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.83e-05	0.00353	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	6.69e-05	0.00346	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.62e-05	0.00342	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.29e-05	0.00325	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.21e-05	0.00321	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.19e-05	0.0032	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.11e-05	0.00316	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.96e-05	0.00308	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.91e-05	0.00306	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.91e-05	0.00306	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.91e-05	0.00306	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.88e-05	0.00304	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	5.82e-05	0.00301	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	5.82e-05	0.00301	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	5.81e-05	0.00301	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.78e-05	0.00299	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.68e-05	0.00294	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.63e-05	0.00291	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.54e-05	0.00287	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.32e-05	0.00275	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.3e-05	0.00274	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.25e-05	0.00272	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.24e-05	0.00271	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.23e-05	0.00271	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.22e-05	0.0027	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.14e-05	0.00266	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.02e-05	0.0026	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.02e-05	0.0026	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.92e-05	0.00254	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.92e-05	0.00254	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.75e-05	0.00246	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.66e-05	0.00241	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.64e-05	0.0024	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.54e-05	0.00235	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.5e-05	0.00233	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.46e-05	0.00231	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.46e-05	0.00231	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.46e-05	0.00231	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.46e-05	0.00231	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.43e-05	0.00229	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.37e-05	0.00226	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.37e-05	0.00226	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.22e-05	0.00218	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.05e-05	0.0021	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.03e-05	0.00209	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	3.99e-05	0.00206	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.96e-05	0.00205	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.96e-05	0.00205	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	3.85e-05	0.00199	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.79e-05	0.00196	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.74e-05	0.00194	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.68e-05	0.00191	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.57e-05	0.00185	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.55e-05	0.00184	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.51e-05	0.00182	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.5e-05	0.00181	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.5e-05	0.00181	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.41e-05	0.00177	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.41e-05	0.00177	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.4e-05	0.00176	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.37e-05	0.00174	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.37e-05	0.00174	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.36e-05	0.00174	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.36e-05	0.00174	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.34e-05	0.00173	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.34e-05	0.00173	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.34e-05	0.00173	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.32e-05	0.00172	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.29e-05	0.0017	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.29e-05	0.0017	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.27e-05	0.00169	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.23e-05	0.00167	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.18e-05	0.00164	CbGpPWpGaD
Remoxipride—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	3.1e-05	0.00161	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.1e-05	0.0016	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.09e-05	0.0016	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.06e-05	0.00158	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.04e-05	0.00157	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.03e-05	0.00157	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.03e-05	0.00157	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.02e-05	0.00156	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.99e-05	0.00155	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.99e-05	0.00154	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.99e-05	0.00154	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.98e-05	0.00154	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.97e-05	0.00154	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.8e-05	0.00145	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.75e-05	0.00143	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.72e-05	0.00141	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.64e-05	0.00136	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.64e-05	0.00136	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.58e-05	0.00133	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.00132	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.0013	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.5e-05	0.00129	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.49e-05	0.00129	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.46e-05	0.00127	CbGpPWpGaD
Remoxipride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.4e-05	0.00124	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.34e-05	0.00121	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.34e-05	0.00121	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.31e-05	0.00119	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.00118	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.27e-05	0.00118	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.27e-05	0.00118	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.25e-05	0.00117	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.24e-05	0.00116	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.11e-05	0.00109	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.08e-05	0.00108	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.07e-05	0.00107	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.05e-05	0.00106	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.01e-05	0.00104	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.98e-05	0.00102	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.95e-05	0.00101	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.91e-05	0.000986	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.88e-05	0.000971	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.81e-05	0.000935	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.79e-05	0.000927	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.79e-05	0.000927	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.78e-05	0.000922	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.77e-05	0.000915	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.76e-05	0.000913	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.76e-05	0.000913	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.76e-05	0.000908	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.73e-05	0.000895	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.61e-05	0.000831	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.57e-05	0.000812	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.000706	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000695	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.34e-05	0.000694	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000685	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.32e-05	0.000684	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.3e-05	0.000674	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000636	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000625	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000622	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.18e-05	0.000612	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.04e-05	0.00054	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.04e-05	0.000538	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.28e-06	0.00048	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.23e-06	0.000478	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.1e-06	0.000367	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.06e-06	0.000365	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.98e-06	0.000361	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.95e-06	0.00036	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.14e-06	0.000318	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.11e-06	0.000316	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.45e-06	0.000282	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.17e-06	0.000216	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.1e-06	0.000212	CbGpPWpGaD
